Healthcare provider profile · identity verified

Mark S Roberto, M.D.

Family Practice · SPRINGFIELD, OH · NPI 1750384681

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	443	109
Metoprolol Succinate	Metoprolol Succinate	298	79
Rosuvastatin Calcium	Rosuvastatin Calcium	270	81
Amlodipine Besylate	Amlodipine Besylate	253	62
Pantoprazole Sodium	Pantoprazole Sodium	246	73
Levothyroxine Sodium	Levothyroxine Sodium	214	51
Losartan Potassium	Losartan Potassium	205	50
Montelukast Sodium	Montelukast Sodium	170	52
Furosemide	Furosemide	157	45
Gabapentin	Gabapentin	157	52
Omeprazole	Omeprazole	146	43
Carvedilol	Carvedilol	144	33
Alprazolam	Alprazolam	139	33
Eliquis	Apixaban	128	34
Clopidogrel	Clopidogrel Bisulfate	127	40
Tamsulosin Hcl	Tamsulosin Hcl	117	42
Metformin Hcl	Metformin Hcl	113	37
Glimepiride	Glimepiride	111	31
Sertraline Hcl	Sertraline Hcl	101	25
Metoprolol Tartrate	Metoprolol Tartrate	99	29
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	98	34
Synthroid	Levothyroxine Sodium	88	25
Lisinopril	Lisinopril	83	27
Albuterol Sulfate Hfa	Albuterol Sulfate	82	30
Trazodone Hcl	Trazodone Hcl	81	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	78	19
Lorazepam	Lorazepam	77	19
Methylprednisolone	Methylprednisolone	73	47
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	73	13
Allopurinol	Allopurinol	67	20
Isosorbide Mononitrate Er	Isosorbide Mononitrate	67	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	65	18
Potassium Chloride	Potassium Chloride	64	19
Xarelto	Rivaroxaban	62	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	59	18
Atenolol	Atenolol	57	18
Tramadol Hcl	Tramadol Hcl	55	16
Mirtazapine	Mirtazapine	54	12
Memantine Hcl	Memantine Hcl	53	suppressed
Simvastatin	Simvastatin	53	21
Januvia	Sitagliptin Phosphate	52	17
Prednisone	Prednisone	52	20
Fluticasone Propionate	Fluticasone Propionate	51	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	49	16
Bupropion Xl	Bupropion Hcl	48	13
Famotidine	Famotidine	46	17
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	44	suppressed
Celecoxib	Celecoxib	43	14
Ramipril	Ramipril	43	12
Azithromycin	Azithromycin	42	34
Glipizide	Glipizide	42	11
Metformin Hcl Er	Metformin Hcl	40	13
Pravastatin Sodium	Pravastatin Sodium	40	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	39	12
Ibandronate Sodium	Ibandronate Sodium	39	11
Alendronate Sodium	Alendronate Sodium	38	suppressed
Diclofenac Sodium	Diclofenac Sodium	38	12
Bromocriptine Mesylate	Bromocriptine Mesylate	36	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	35	14
Buspirone Hcl	Buspirone Hcl	34	suppressed
Duloxetine Hcl	Duloxetine Hcl	34	12
Escitalopram Oxalate	Escitalopram Oxalate	34	11
Venlafaxine Hcl Er	Venlafaxine Hcl	34	suppressed
Amlodipine-Atorvastatin	Amlodipine/Atorvastatin	33	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	33	suppressed
Ozempic	Semaglutide	33	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	31	25
Glipizide Er	Glipizide	31	suppressed
Lansoprazole	Lansoprazole	31	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	31	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	31	suppressed
Donepezil Hcl	Donepezil Hcl	30	11
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	30	suppressed
Paroxetine Hcl	Paroxetine Hcl	30	11
Dexlansoprazole Dr	Dexlansoprazole	28	suppressed
Spironolactone	Spironolactone	28	14
Torsemide	Torsemide	28	suppressed
Trulicity	Dulaglutide	28	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	28	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Estradiol	Estradiol	27	suppressed
Farxiga	Dapagliflozin Propanediol	27	suppressed
Fluconazole	Fluconazole	27	11
Hydrochlorothiazide	Hydrochlorothiazide	27	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	26	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	25	suppressed
Clonidine Hcl	Clonidine Hcl	25	suppressed
Finasteride	Finasteride	25	suppressed
Ezetimibe	Ezetimibe	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Potassium Citrate Er	Potassium Citrate	23	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	23	suppressed
Tizanidine Hcl	Tizanidine Hcl	23	11
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	23	12
Ibuprofen	Ibuprofen	21	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Entresto	Sacubitril/Valsartan	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	suppressed
Aripiprazole	Aripiprazole	19	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Memantine Hcl Er	Memantine Hcl	19	suppressed
Ondansetron Odt	Ondansetron	19	suppressed
Warfarin Sodium	Warfarin Sodium	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	16
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	18	suppressed
Meloxicam	Meloxicam	18	suppressed
Nitroglycerin	Nitroglycerin	18	13
Doxycycline Hyclate	Doxycycline Hyclate	17	12
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Sildenafil Citrate	Sildenafil Citrate	17	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	16	suppressed
Jardiance	Empagliflozin	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	14
Telmisartan	Telmisartan	16	suppressed
Topiramate	Topiramate	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	15	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	15	suppressed
Naproxen	Naproxen	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Cephalexin	Cephalexin	14	14
Doxepin Hcl	Doxepin Hcl	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Linzess	Linaclotide	14	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	14	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Tresiba Flextouch U-200	Insulin Degludec	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Repatha Sureclick	Evolocumab	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Dextroamphetamine Sulfate	Dextroamphetamine Sulfate	11	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	11	suppressed
Livalo	Pitavastatin Calcium	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error